Detection and identification of protein citrullination in complex biological systems

Current Opinion in Chemical Biology

Volumn 30, Issue , 2016, Pages 1-6

  Clancy, Kathleen W ^a,b   Weerapana, Eranthie ^c   Thompson, Paul R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ARGININE; CITRULLINE; PROTEIN;

ASSAY; CITRULLINATION; DERIVATIZATION; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN MODIFICATION; REVIEW; ANIMAL; CHEMISTRY; HUMAN; METABOLISM; PROTEIN PROCESSING;

ANIMALS; ARGININE; CITRULLINE; HUMANS; MASS SPECTROMETRY; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 84945289898     PISSN: 13675931     EISSN: 18790402     Source Type: Journal    
DOI: 10.1016/j.cbpa.2015.10.014     Document Type: Review

References (52)

1. Wang Y., et al. Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity. J Biol Chem 2012, 287:25941-25953.
2. Hemmers S., et al. PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLoS ONE 2011, 6:pe22043.
3. Knight J.S., et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest 2013, 123:2981-2993.
4. Knight J.S., et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis 2014, 10.1136/annrheumdis-2014-205365.
5. Zhang X., et al. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor alpha target gene activation. Proc Natl Acad Sci U S A 2012, 109:13331-13336.
6. McElwee J.L., et al. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer 2012, 12:500.
7. Wang Y., et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 2004, 306:279-283.
8. Cuthbert G.L., et al. Histone deimination antagonizes arginine methylation. Cell 2004, 118:545-553.
9. Bizzaro N., et al. Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001, 47:1089-1093.
10. De Rycke L., et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum 2005, 52:2323-2330.
11. Ordonez A., et al. Increased levels of citrullinated antithrombin in plasma of patients with rheumatoid arthritis and colorectal adenocarcinoma determined by a newly developed ELISA using a specific monoclonal antibody. Thromb Haemost 2010, 104:1143-1149.
12. Raijmakers R., et al. Elevated levels of fibrinogen-derived endogenous citrullinated peptides in synovial fluid of rheumatoid arthritis patients. Arthritis Res Ther 2012, 14:pR114.
13. Farid S., Azizi G., Mirshafiey A. Anti-citrullinated protein antibodies and their clinical utility in rheumatoid arthritis. Int J Rheum Dis 2013, 16:379-386.
14. Kim S., et al. Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis. PLOS ONE 2014, 9:pe97501.
15. Rondas D., et al. Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes. Diabetes 2015, 64:573-586.
16. Elkon K.B., Wiedeman A. Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 2012, 24:499-505.
17. Chumanevich A.A., et al. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am J Physiol Gastrointest Liver Physiol 2011, 300:G929-G938.
18. Bicker K.L., et al. Seeing citrulline: development of a phenylglyoxal-based probe to visualize protein citrullination. J Am Chem Soc 2012, 134:17015-17018.
19. Mastronardi F.G., et al. Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent. J Neurosci Res 1996, 44:301-307.
20. Mastronardi F.G., et al. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. J Clin Invest 1996, 97:349-358.
21. Musse A.A., et al. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech 2008, 1:229-240.
22. Yon M., et al. Identification of a mitogen-activated protein kinase site in human myelin basic protein in situ. J Neuroimmunol 1996, 65:55-59.
23. Nicholas A.P. Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neurosci Lett 2011, 495:26-29.
24. Acharya N.K., et al. Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. J Autoimmun 2012, 38:369-380.
25. Nicholas A.P. Dual immunofluorescence study of citrullinated proteins in Alzheimer diseased frontal cortex. Neurosci Lett 2013, 545:107-111.
26. Stadler S.C., et al. Dysregulation of PAD4-mediated citrullination of nuclear GSK3beta activates TGF-beta signaling and induces epithelial-to-mesenchymal transition in breast cancer cells. Proc Natl Acad Sci U S A 2013, 110:11851-11856.
27. Mohanan S., et al. Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. Biochem Res Int 2012, 2012:895343.
28. Wang Y., et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009, 184:205-213.
29. Schellekens G.A., et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998, 101:273-281.
30. Girbal-Neuhauser E., et al. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol 1999, 162:585-594.
31. Chapuy-Regaud S., et al. Fibrin deimination in synovial tissue is not specific for rheumatoid arthritis but commonly occurs during synovitides. J Immunol 2005, 174:5057-5064.
32. Takizawa Y., et al. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis 2006, 65:1013-1020.
33. Chang X., et al. Citrullination of fibronectin in rheumatoid arthritis synovial tissue. Rheumatology (Oxford) 2005, 44:1374-1382.
34. Hueber W., et al. Sensitivity and specificity of anti-Sa autoantibodies for rheumatoid arthritis. Rheumatology (Oxford) 1999, 38:155-159.
35. Schellekens G.A., et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000, 43:155-163.
36. Knipp M., Vasak M. A colorimetric 96-well microtiter plate assay for the determination of enzymatically formed citrulline. Anal Biochem 2000, 286:257-264.
37. Senshu T., et al. Detection of citrulline residues in deiminated proteins on polyvinylidene difluoride membrane. Anal Biochem 1992, 203:94-100.
38. Moelants E.A., Van Damme J., Proost P. Detection and quantification of citrullinated chemokines. PLoS ONE 2011, 6:pe28976.
39. Nicholas A.P., Whitaker J.N. Preparation of a monoclonal antibody to citrullinated epitopes: its characterization and some applications to immunohistochemistry in human brain. Glia 2002, 37:328-336.
40. Nicholas A.P., et al. Immunohistochemical localization of citrullinated proteins in adult rat brain. J Comp Neurol 2003, 459:251-266.
41. Makrygiannakis D., et al. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis 2008, 67:1488-1492.
42. Raats J.M., et al. Recombinant human monoclonal autoantibodies specific for citrulline-containing peptides from phage display libraries derived from patients with rheumatoid arthritis. J Rheumatol 2003, 30:1696-1711.
43. van Beers J.J., et al. The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin. Arthritis Rheum 2013, 65:69-80.
44. Jin Z., et al. Identification and characterization of citrulline-modified brain proteins by combining HCD and CID fragmentation. Proteomics 2013, 13:2682-2691.
45. Fert-Bober J., et al. Citrullination of myofilament proteins in heart failure. Cardiovasc Res 2015.
46. Holm A., et al. Specific modification of peptide-bound citrulline residues. Anal Biochem 2006, 352:68-76.
47. De Ceuleneer M., et al. Modification of citrulline residues with 2,3-butanedione facilitates their detection by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 2011, 25:1536-1542.
48. Choi M., et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of peptide citrullination site using Br signature. Anal Biochem 2013, 437:62-67.
49. Tutturen A.E., Fleckenstein B., de Souza G.A. Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides. J Proteome Res 2014, 13:2867-2873.
50. Tutturen A.E., Holm A., Fleckenstein B. Specific biotinylation and sensitive enrichment of citrullinated peptides. Anal Bioanal Chem 2013, 405:9321-9331.
51. Lewallen D.M., et al. A chemical proteomic platform to identify citrullinated proteins. ACS Chem Biol 2015.
52. Tutturen A.E., et al. A technique for the specific enrichment of citrulline-containing peptides. Anal Biochem 2010, 403:43-51.